b-cells and pre-plasma cells are important reservoirs responsible for relapse in multiple myeloma
Published 7 months ago • 138 plays • Length 2:28Download video MP4
Download video MP3
Similar videos
-
2:20
the role of myeloma b-cells & pre-plasma cell progenitors in disease relapse following therapy
-
2:00
the potential of studying circulating plasma cells in multiple myeloma
-
3:05
identifying new therapeutic targets on the surfaceome of myeloma plasma cells with proteomics
-
3:00
current & emerging biomarkers in multiple myeloma
-
2:30
a new era of treatment for multiple myeloma
-
2:50
phase i study of abbv383, a novel bcmaxcd3 bispecific antibody, in r/r multiple myeloma
-
2:42
enhancing outcomes in multiple myeloma with immune-based strategies
-
0:48
asciminib for the treatment of cml
-
1:45
the advent of bispecific antibodies for multiple myeloma
-
4:22
prognostic value of mrd and circulating plasma cells in myeloma
-
1:53
the future of multiple myeloma treatment
-
3:24
novel agents for the management of r/r myeloma
-
0:58
minimumm-seq: a novel, minimally invasive approach to characterize myeloma pathology
-
0:53
using single-cell sequencing to define mechanisms of progression from smm to myeloma
-
2:28
clonal hematopoiesis and implications in multiple myeloma
-
2:58
bcma 2 1 t-cell engager cc-93269 in patients with r/r myeloma
-
0:52
novel strategies to evaluate biomarkers of interest in multiple myeloma
-
2:38
crb-402 study update: t-cell phenotypes in myeloma
-
4:45
a first-in-human trial of linvoseltamab (regn5458) in r/r myeloma: updated phase i data